GTBP   $0.445  -1.00% Market Closed After Close 0.4489 0.88%

GT Biopharma, Inc.
Total Cash 9.25M
totalCashPerShare 4.139
EBITDA
Total Debt 0.00
quickRatio 2.46
currentRatio 2.465
Total Revenue
debtToEquity
Revenue/Share
ROA -0.60592
ROE -1.31481
grossProfits
freeCashflow -8.04M
operatingCashflow -11.71M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -2.57M
forwardPE
floatShares 1.67M
sharesOutstanding 2.23M
sharesShort 10.38K
sharesShortPriorMonth 7.76K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.68%
Short Ratio help_outline 0.71%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 2.465
Price To Book help_outline 1.21
earningsQuarterlyGrowth
netIncomeToCommon -11.35M
trailingEps -8.00%
forwardEps -10.80%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 23
lastUpdated Nov. 7, 2024, 4:55 a.m.